SC 13G/A

AMENDMENT NO. 17 TO SCHEDULE 13G

Company: Corbus Pharmaceuticals Holdings, Inc.
Filed: February 14, 2022
Accession Number: 0001213900-22-007461

View Document ↗ View on SEC.gov ↗